Korea Moves to Garner More Roche Tamiflu, GSK Relenza Against Swine Flu
This article was originally published in PharmAsia News
Executive Summary
SEOUL - The South Korean government is moving quickly to garner more of Roche's Tamiflu (oseltamivir) and Biota's Relenza (zanamivir) in its prevention against the swine flu virus reported in Mexico, the U.S. and the UK